Syntopix is a speciality pharmaceutical research and development company.
We seek to identify compounds and develop products that treat dermatological conditions, principally acne and staphylococcal infections including MRSA.
We are committed to improving the health and appearance of our consumers by offering safe and effective treatments of the highest quality, thereby creating value for our shareholders and employees.